Literature DB >> 31554763

Statin Intolerance-An Asian Perspective.

Brian Tomlinson1,2, Paul Chan3, Zhong-Min Liu4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31554763      PMCID： PMC7242232          DOI： 10.5551/jat.50435

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN： 1340-3478            Impact factor:   4.928


× No keyword cloud information.
  17 in total

1.  Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update.

Authors:  G B John Mancini; A Yashar Tashakkor; Steven Baker; Jean Bergeron; David Fitchett; Jiri Frohlich; Jacques Genest; Milan Gupta; Robert A Hegele; Dominic S Ng; Glen J Pearson; Janet Pope
Journal:  Can J Cardiol       Date:  2013-09-29       Impact factor: 5.223

2.  A case of simvastatin-induced myopathy with SLCO1B1 genetic predisposition and co-ingestion of linagliptin and Stevia rebaudiana.

Authors:  Jones Chun Man Chan; Ming-Him Ng; Raymond Siu Ming Wong; Brian Tomlinson
Journal:  J Clin Pharm Ther       Date:  2019-02-03       Impact factor: 2.512

3.  Treatment Patterns, Statin Intolerance, and Subsequent Cardiovascular Events Among Japanese Patients With High Cardiovascular Risk Initiating Statin Therapy.

Authors:  Saurabh P Nagar; Pratik P Rane; Kathleen M Fox; Juliana Meyers; Keith Davis; Anne Beaubrun; Hyoe Inomata; Yi Qian; Kouji Kajinami
Journal:  Circ J       Date:  2017-12-23       Impact factor: 2.993

4.  Prevalence of vitamin D insufficiency among adolescents and its correlation with bone parameters using high-resolution peripheral quantitative computed tomography.

Authors:  T F Cheung; K Y Cheuk; F W P Yu; V W Y Hung; C S Ho; T Y Zhu; B K W Ng; K M Lee; L Qin; S S Y Ho; G W K Wong; J C Y Cheng; T P Lam
Journal:  Osteoporos Int       Date:  2016-03-24       Impact factor: 4.507

Review 5.  Evaluating the efficacy and safety of atorvastatin + ezetimibe in a fixed-dose combination for the treatment of hypercholesterolemia.

Authors:  Ya-Bin Ma; Paul Chan; Yuzhen Zhang; Brian Tomlinson; Zhongmin Liu
Journal:  Expert Opin Pharmacother       Date:  2019-03-25       Impact factor: 3.889

6.  Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.

Authors:  Steven E Nissen; Erik Stroes; Ricardo E Dent-Acosta; Robert S Rosenson; Sam J Lehman; Naveed Sattar; David Preiss; Eric Bruckert; Richard Ceška; Norman Lepor; Christie M Ballantyne; Ioanna Gouni-Berthold; Mary Elliott; Danielle M Brennan; Scott M Wasserman; Ransi Somaratne; Rob Scott; Evan A Stein
Journal:  JAMA       Date:  2016-04-19       Impact factor: 56.272

7.  Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab.

Authors:  Erik Stroes; David Colquhoun; David Sullivan; Fernando Civeira; Robert S Rosenson; Gerald F Watts; Eric Bruckert; Leslie Cho; Ricardo Dent; Beat Knusel; Allen Xue; Rob Scott; Scott M Wasserman; Michael Rocco
Journal:  J Am Coll Cardiol       Date:  2014-03-30       Impact factor: 24.094

Review 8.  Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.

Authors:  Erik S Stroes; Paul D Thompson; Alberto Corsini; Georgirene D Vladutiu; Frederick J Raal; Kausik K Ray; Michael Roden; Evan Stein; Lale Tokgözoğlu; Børge G Nordestgaard; Eric Bruckert; Guy De Backer; Ronald M Krauss; Ulrich Laufs; Raul D Santos; Robert A Hegele; G Kees Hovingh; Lawrence A Leiter; Francois Mach; Winfried März; Connie B Newman; Olov Wiklund; Terry A Jacobson; Alberico L Catapano; M John Chapman; Henry N Ginsberg
Journal:  Eur Heart J       Date:  2015-02-18       Impact factor: 29.983

9.  Statin Responses in Chinese Patients.

Authors:  Brian Tomlinson; Paul Chan; Zhong-Min Liu
Journal:  J Atheroscler Thromb       Date:  2017-07-21       Impact factor: 4.928

Review 10.  Diagnosis and Management of Statin Intolerance.

Authors:  Rodrigo Alonso; Ada Cuevas; Alberto Cafferata
Journal:  J Atheroscler Thromb       Date:  2019-01-19       Impact factor: 4.928
View more
  3 in total

1.  Causes and outcome of rhabdomyolysis in patients admitted to medical wards in the Prince of Wales Hospital.

Authors:  Weiwei Zeng; Brian Tomlinson
Journal:  Ann Transl Med       Date:  2021-08

2.  Impact of Statin Treatment Intensity after Endovascular Revascularization on Lower Extremity Peripheral Artery Disease.

Authors:  Gwang Sil Kim; Jongkwon Seo; Byung Gyu Kim; Moo-Nyun Jin; Hye Young Lee; Byung Ok Kim; Young Sup Byun
Journal:  Yonsei Med J       Date:  2022-04       Impact factor: 2.759

Review 3.  Tackling cardiometabolic risk in the Asia Pacific region.

Authors:  Jian-Jun Li; Khung Keong Yeo; Kathyrn Tan; Junya Ako; Rungroj Krittayaphong; Ru San Tan; Philip E Aylward; CarolynS P Lam; Sang Hong Baek; Jamshed Dalal; Alan Fong; Yi-Heng Li; Richard C O'Brien; Si Ya Natalie Koh; Daniel J Scherer; Hayato Tada; Vernon Kang; Julie Butters; Stephen J Nicholls
Journal:  Am J Prev Cardiol       Date:  2020-11-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.